Today: 20 March 2026
Subscribe
Browse Category

ASX:PME 24 November 2025 - 6 March 2026

Why Pro Medicus (ASX:PME) shares jumped 4.6% today

Why Pro Medicus (ASX:PME) shares jumped 4.6% today

Pro Medicus shares jumped 4.6% to A$121.49 on Thursday, valuing the company at about A$12.1 billion. The stock remains down 53% over the past year despite recent gains. Interim results showed revenue up 28.4% to A$124.8 million, with profit boosted by a large fair value gain on a 4D Medical investment. An on-market buyback is underway through March 2026.
5 March 2026
··
ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech

ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech

ASX 200 futures traded around 8,988 early Tuesday, about 0.4% below Monday’s close after the index fell 0.61% on U.S. tariff uncertainty. Growth stocks and banks dropped, while resources and gold miners outperformed. The Australian dollar slipped 0.2% to 70.68 U.S. cents. Traders await January inflation data due Wednesday.
23 February 2026
········
ASX 200 Today: Index Rebounds From Near Six‑Month Low as Banks, Miners Lift the Market – 24 November 2025

ASX 200 Today: Index Rebounds From Near Six‑Month Low as Banks, Miners Lift the Market – 24 November 2025

The S&P/ASX 200 rose about 1.1% to 8,507 by late morning Monday, rebounding after a 1.6% drop Friday that erased nearly $40 billion in value. All major sectors traded higher, led by financials and industrials. The index remains roughly 7–8% below its October record high, following four straight weekly losses. Investors await a key inflation report due Wednesday.
24 November 2025
·····

Stock Market Today

  • CAFO.PA Oversold Bounce Setup at €7.92 on EURONEXT
    March 19, 2026, 9:20 PM EDT. CAFO.PA stock trades at €7.92 pre-market on EURONEXT, near its yearly low of €7.42 after a 6.82% drop over five days. The stock shows an oversold bounce opportunity amid thin volume of 46 shares versus a 50-day average of 787, signaling a fragile rebound. With a market cap of €72.8 million, trailing PE of 4.92 indicates deep value compared to its sector, which averages a PE of 19.27. Price sits just below the 200-day moving average, near support at €7.42 and resistance at €8.04, favoring mean-reversion trades. Risks include geographical concentration and weak interest coverage, with limited catalysts ahead. Traders should apply strict risk management, using limit orders and tight stops given low liquidity. Meyka AI assigns a HOLD rating with a score of 68.71, reflecting measured upside potential.
Go toTop